Endoscopy 2022; 54(S 01): S184
DOI: 10.1055/s-0042-1745062
Abstracts | ESGE Days 2022
ESGE Days 2022 Digital poster exhibition

INTRODUCTION OF A 3RD GENERATION FNB NEEDLE IN COMMUNITY HOSPITAL PRACTICE INCREASES QUALITY AND YIELD OF EUS-GUIDED TA OF SOLID PANCREATIC LESIONS

H.M. Schutz
1   Reinier de Graaf Gasthuis, Gastroenterology and Hepatology, Delft, Netherlands
,
M.-P.G. Anten
2   Franciscus Gasthuis en Vlietland, Gastroenterology and Hepatology, Rotterdam, Netherlands
,
I. Leeuwenburgh
2   Franciscus Gasthuis en Vlietland, Gastroenterology and Hepatology, Rotterdam, Netherlands
,
K.J. Hoogduin
3   Pathan, Cyto- and Histopathology, Rotterdam, Netherlands
,
M.J. Bruno
4   Erasmus University Medical Center, Gastroenterology and Hepatology, Rotterdam, Netherlands
,
L.M. van Driel
4   Erasmus University Medical Center, Gastroenterology and Hepatology, Rotterdam, Netherlands
,
R. Quispel
1   Reinier de Graaf Gasthuis, Gastroenterology and Hepatology, Delft, Netherlands
› Author Affiliations
› Further Information
Also available at
 

Aims The ASGE has formulated three quality indicators (KPI) for EUS-guided TA according to a specific performance target (PT): rate of adequate sample (PT 85%), diagnostic yield of malignancy (PT 70%) and sensitivity for malignancy (PT 85%). Feedback on performance is provided to collaborating centers of the Dutch Quality in endosonography team (QUEST) annually using these KPIs. In this study we report the effect of implementation of a 3rd generation FNB needle in one of the collaborating community hospitals on KPIs.

Methods A prospective registration of all EUS-guided TA procedures of solid pancreatic lesions in five community hospitals in the Rotterdam region, the Netherlands started in January 2015. In hospital A, all three KPIs were obtained before and after implementation of the Medtronic SharkCore needle in January 2019.

Results Before introduction of the new needle, the quality was below the predefined PTs. During the ‘learning period’ of the first six months, the new needle was used in 50% of the cases coinciding with a temporary further decrease of KPIs. After this 6 month episode, the new needle was used in 100% of cases and the KPIs improved up to the predefined PT ([Table 1]).

Table 1 Differences in KPIs between different periods in hospital A.

▶Table 1

Differences in KPIs between different periods in hospital A.

1 Jan 2015 – 31 Dec 2018 (n=87)

1 Jan 2019 – 1 Aug 2019 (n=37)

1 Aug 2019 – 31 Dec 2020 (n=47)

Rate of adequate sample

75 (86%)

26 (70%)

45 (96%)

Diagnostic yield of malignancy

53 (61%)

17 (46%)

33 (70%)

Sensitivity for malignancy

68%

46%

72%

Conclusions Continued registration of quality and yield proves to be of great help to monitor changes in quality, especially when new devices or methods are introduced. With the introduction of a 3rd generation FNB needle, after an initial and temporary decrease (‘learning curve’), the quality of EUS-guided TA of solid pancreatic lesions improved up to the predefined PTs.



Publication History

Article published online:
14 April 2022

© 2022. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany